PHA Classroom: e-Learning. Anytime. Anyplace.

>> Back to Recordings

Pediatric PH 101

October 30, 2013

This webinar reviewed the current PH medications used to treat children and described novel therapies that may be studied in children.

This webinar is part of our Parents Telephone Support Group. Learn more about upcoming Parents Telephone Support Group calls.

   

Presenter Information

Dunbar Ivy, MD

Dunbar Ivy, MD
Professor of Pediatrics; Chief and Selby's Chair of Pediatric Cardiology; Director, Pulmonary Hypertension Program, University of Colorado Denver School of Medicine, The Children's Hospital

Dunbar Ivy, MD, is currently the Section Head of Pediatric Cardiology and the Director of the Pediatric Pulmonary Hypertension Program at the University of Colorado. Dr Ivy has been treating patients with PH since 1994. Dr. Ivy has helped run over 20 research trials and is an investigator in the National Institutes of Health-sponsored Specialized Centers of Clinically Oriented Research grant. He has published over 100 medical articles, primarily focusing on pulmonary hypertension in children. His particular areas of medical interest include treatment of pulmonary hypertension, and proteomics of pulmonary vascular disease.

 

 

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
Webmaster@PHAssociation.org
    Privacy Policy   Virtual Tour of Website    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2014 Pulmonary Hypertension Association. All Rights Reserved.

NORD

The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.